Unexpected Hair Growth Induced by Gefitinib Treatment in Two Patients with EGFR Gene Mutation-Positive Adenocarcinoma of the Lung

    September 2015
    Kunihiko Yoshimura, Miho Ejima
    Studysummary In this report, two cases of non-small cell lung cancer treated with gefitinib showed unexpected hair growth, suggesting a potential new application of EGFR-TKIs for alopecia.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on publications.ersnet.org →
    Discuss this study in the Community →